JCO Global Oncology

American Society of Clinical Oncology

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

JCO Global Oncology is an open-access journal published by American Society of Clinical Oncology in United States, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,472 USD. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
American Society of Clinical Oncology
ISSN
2687-8941
Country
United States
Languages
english
Access
Open access
Declared publication charge
2,472 USD
Articles in DOAJ
1466
Declared review time
7 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-01-21
  • MEDLINE · 2020-01-01
Indexing
DOAJ · MEDLINE
APC
2,472 USD
Declared review time (DOAJ)
7 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1466

Most recent article

last month

Average review time (journal-declared via DOAJ)

7weeks

Works in OpenAlex

1847

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

48

i10-index

423

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2022-01-31
Added to DOAJ
2021-01-21
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
78%
ORCID iDs in current deposits
79%
Enrolled in Crossref Similarity Check
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity4
Alternate titles
Global oncologyJCO Glob OncolJCO GO
Continues
2378-9506
Source type
journal
NLM unique ID (PubMed)
101760170
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Cervical Cancer and HPV Research
  • Cervical Cancer and HPV Research
Show all subjects (50)
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Global Health and Surgery
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Cancer survivorship and care
  • Global Health and Surgery
  • COVID-19 and healthcare impacts
  • COVID-19 and healthcare impacts
  • Cancer survivorship and care
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Ethics in Clinical Research
  • Ethics in Clinical Research
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Palliative Care and End-of-Life Issues
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Palliative Care and End-of-Life Issues
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Screening and Detection
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Endometrial and Cervical Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Risks and Factors
  • Lymphoma Diagnosis and Treatment
  • Cancer Risks and Factors
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research

Keywords (DOAJ)

  • low and middle income countries
  • oncology
  • cancer
  • health services

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: